Entries by Thomas Gabrielczyk

Speedy DNA extraction from buccal swabs & FFPE samples

BioEcho Life Sciences develops innovative products that drastically improve the quality, convenience, and speed of standard molecular protocols. The EchoLUTION technology consists of an efficient and gentle lysis, followed by a unique single-step centrifugation, which provides a reduction of procedural steps compared to conventional kits, and considerably reduces plastic waste.

Vector BioPharma: the future of gene delivery

Precision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge and, with cutting-edge technology from the University of Zürich, is developing a revolutionary new way to deliver the right genes to the right place at the right time. Vector BioPharma aims to be the pioneer in delivering future medicines with this technology, now under development in multiple areas of urgent medical need.

Crossing the commercialisation chasm

As a late-stage investor focusing on the European bioeconomy, the ECBF is carefully assessing the maturity of any technology, but more important than maturity is the ability to reach commercial scale. What governs that scale-up, and how do we assess it? What role does the TRL score play, and what key questions do we ask? An excerpt into a framework.

CDMO excellence in phytocannabinoid products

CB21 Pharma Ltd announces that it entered a global strategic collaboration to combine
its leading expertise and clinical research program in phytocannabinoids with world-class
pharmaceutical strategic consulting and business development services of NorthStar Corporate Finance Ltd and Kru?ger Beteiligungs GmbH, forming a new company called CB21 R&D.

24th Guide to German Biotech Companies

The 24th edition is showcasing almost 150 companies with detailed portraits in English on 300 colored pages: small and medium-sized companies with a focus on research and development as well as successful global players. The guide is the international business card of Germanys biotechnology industry.

Sourcing innovation in the Life Sciences sector

BioFIT is Europe’s leading partnering event in Life Sciences for tech transfer, early-stage innovation deals and pre-seed, seed and Series A investment, receiving each year more than 1,000 delegates from over 35 countries. For its 11th edition, BioFIT will be held in Strasbourg, France on November 29th and 30th, and on a digital format on December 7th and 8th.